Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

This study has been completed.
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Temple University
University of Michigan
Ohio University
Information provided by (Responsible Party):
Guillermo Umpierrez, Emory University
ClinicalTrials.gov Identifier:
NCT01845831
First received: April 30, 2013
Last updated: April 12, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)